Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe (Q26795706)

inferred from title

Rift Valley fever virus

Rift Valley fever virus

1 reference

inferred from title

Rift Valley fever virus

0 references

Nicholas Johnson

4

0 references

Daniel L. Horton

Daniel L Horton

5

0 references

Anthony R. Fooks

7

Anthony R Fooks

0 references

Ashley C. Banyard

2

Ashley C Banyard

0 references

Luis Hernandez-Triana

6

Luis M Hernández-Triana

0 references

author name string

Karen L Mansfield

1

0 references

Lorraine McElhinney

The pathogenesis of Rift Valley fever

3

0 references

language of work or name

English

0 references

publication date

13 October 2015

0 references

published in

Vaccine

0 references

volume

33

0 references

issue

42

0 references

page(s)

5520-31

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Molecular biology of the Bunyaviridae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

7 January 2021

Rift Valley fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Experimental Rift Valley fever in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Manifestations of severe Rift Valley fever in Sudan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The Historical and Recent Impact of Rift Valley Fever in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Vertical transmission of fatal Rift Valley fever in a newborn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Patterns of Rift Valley fever activity in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

An RVF epidemic in southern Mauritania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever among domestic animals in the recent West African outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Molecular and serological studies on the Rift Valley fever outbreak in Mauritania in 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever on the east coast of Madagascar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley Fever, Mayotte, 2007–2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Molecular biology and genetic diversity of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The status of Rift Valley fever in animals in Saudi Arabia: a mini review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Breaking the chain: Rift Valley fever virus control via livestock vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Comparison of techniques for demonstrating antibodies to Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Development and Evaluation of a Real-Time Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Rift Valley Fever Virus in Clinical Specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Creation of a nonspreading Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Development of a RVFV ELISA that can distinguish infected from vaccinated animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Comparison of enzyme-linked immunosorbent assay-based techniques for the detection of antibody to Rift Valley fever virus in thermochemically inactivated sheep sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Simultaneous detection of IgG antibodies associated with viral hemorrhagic fever by a multiplexed Luminex-based immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Human infection with Rift Valley fever virus and immunity twelve years after single attack.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rapid detection of important human pathogenic Phleboviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Sensitivity and specificity of real-time reverse transcription polymerase chain reaction, histopathology, and immunohistochemical labeling for the detection of Rift Valley fever virus in naturally infected cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Macroarray assay for differential diagnosis of meningoencephalitis in southern Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Real-Time Reverse-Transcription Loop-Mediated Isothermal Amplification for Rapid Detection of Rift Valley Fever Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

International external quality assessment of molecular detection of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Using a field quantitative real-time PCR test to rapidly identify highly viremic rift valley fever cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Blood meal analysis and virus detection in blood-fed mosquitoes collected during the 2006-2007 Rift Valley fever outbreak in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Capripoxvirus-vectored vaccines against livestock diseases in Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

First serological investigation of peste-des-petits-ruminants and Rift Valley fever in Tunisia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift valley fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Comparative efficacy of two next-generation Rift Valley fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

RNA virus reverse genetics and vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Creation of a recombinant Rift Valley fever virus with a two-segmented genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Development of a novel, single-cycle replicable rift valley Fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Prediction of a Rift Valley fever outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The AFHSC-Division of GEIS Operations Predictive Surveillance Program: a multidisciplinary approach for the early detection and response to disease outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Data-driven modeling to assess receptivity for Rift Valley Fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Risk of a rift valley fever epidemic at the haj in Mecca, Saudi Arabia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Potential vectors of Rift Valley fever virus in the Mediterranean region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift valley fever: recent insights into pathogenesis and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Possible vectors of Rift Valley fever in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

New vectors of Rift Valley fever in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Laboratory transmission of Rift Valley fever virus by Phlebotomus duboscqi, Phlebotomus papatasi, Phlebotomus sergenti, and Sergentomyia schwetzi (Diptera: Psychodidae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Animal models of Rift Valley fever virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

One Health approach to Rift Valley fever vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

7 January 2021

inferred from DOI database lookup

Genetic reassortment of Rift Valley fever virus in nature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

7 January 2021

inferred from DOI database lookup

Mechanical transmission of Rift Valley fever virus by hematophagous Diptera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.020

7 January 2021